Gary S. Roubin is Director at InspireMD, Inc. (NSPR). They have made 12 open-market trades across 2 companies since 2006, most recently 2026-05-07.
CIK 0001162533
12 open-market purchases totalling $2.0M since 2006, never a sale. Across 10 scored buys the stock is down 6.9% at ninety days, and 11.1 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| NSPR | 834,478 | $417K |
| LIPD | 115,574 | — |
| Total | $417K |
Shares reported on the most recent Form 4, priced at the 2026-05-08 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 10% | 30% | 30% |
| Avg Move | -8.6% | -9.8% | -6.9% |
| Alpha | -8.2% | -9.7% | -11.1% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NSPR | BUY | 2026-05-07 | 2026-05-08 | $1.18 | $106K | -19.8% | -35.6% | -42.9% |
| NSPR | BUY | 2025-07-30 | 2025-08-01 | $2.42 | $200K | -13.5% | -15.9% | -24.2% |
| NSPR | BUY | 2023-11-30 | 2023-12-04 | $2.53 | $253K | -10.5% | +1.6% | +0.0% |
| NSPR | BUY | 2023-05-12 | 2023-05-16 | $1.63 | $200K | -6.8% | +16.5% | +78.4% |
| NSPR | BUY | 2022-08-18 | 2022-08-22 | $1.91 | $68K | -3.4% | -7.9% | -35.4% |
| NSPR | BUY | 2021-12-28 | 2021-12-30 | $3.08 | $101K | +1.3% | -9.4% | +6.7% |
| NSPR | BUY | 2021-11-17 | 2021-11-18 | $3.86 | $199K | +0.0% | -7.3% | -27.2% |
| NSPR | BUY | 2021-08-25 | 2021-08-26 | $4.19 | $186K | -2.0% | +8.7% | -12.6% |
| NSPR | BUY | 2021-02-08 | 2021-02-10 | $0.62 | $300K | -26.6% | -42.8% | -74.2% |
| NSPR | BUY | 2020-10-16 | 2020-10-19 | $0.45 | $200K | -4.6% | -5.5% | +62.6% |
| LIPD | BUY | 2007-06-11 | 2007-06-12 | $1.41 | $70K | N/A | N/A | N/A |
| LIPD | BUY | 2006-08-08 | 2006-08-10 | $1.26 | $75K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.